Evaluation of depth filtration to remove prion challenge from an immune globulin preparation

Vox Sanguinis

Volumn 85, Issue 1, 2003, Pages 20-24

  Van Holten, Robert W ^a   Autenrieth, S M ^a  

^a Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Blood proteins isolation and purification; Filtration; Immune globulins; Prions; PrPSc; Transmissible spongiform encephalopathies

Indexed keywords

IMMUNOGLOBULIN; LYSOPHOSPHATIDYLCHOLINE; METHANOL; PLASMA PROTEIN; PRION PROTEIN; SODIUM CHLORIDE; TROMETAMOL;

ADSORPTION; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DISEASE TRANSMISSION; FILTRATION; HAMSTER; MEMBRANE FILTER; NONHUMAN; PARTICLE SIZE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; SCRAPIE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CRICETINAE; FILTRATION; IMMUNOGLOBULINS, INTRAVENOUS; MEMBRANES, ARTIFICIAL; PRION DISEASES; PRPSC PROTEINS;

EID: 0037674975     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2003.00312.x     Document Type: Article

References (15)

1. Burnouf T, Radosevich M: Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000; 14:94-110
2. Turner ML, Ironside JW: New-variant Creutzfeldt-Jacob disease: the risk of transmission by blood transfusion. Blood Rev 1998; 12:255-268
3. Foster P: Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy. Transfus Med 1999; 9:3-14
4. Lee DC, Stenland CJ, Hartwell RC, Ford EK, Cai K, Miller JLC, Gilligan KJ, Rubenstein R, Fournel M, Petteway SR: Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods 2000; 84:77-89
5. Foster PR, Welch AG, McLean C, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey AC: Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sang 2000; 78:86-95
6. Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, Rubenstein R, Fournel M, Petteway SR: A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion 2001; 41:449-455
7. Van Holten R, Autenrieth S, Boose JA, Hsieh WT, Dolan S: Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter. Transfusion 2002; 42:999-1004
8. Hou KC, Ostreicher EA (inventors): Cuno Incorporated, assignee. Filter Sheet. US patent 4,859,340, August 22 1989. Washington DC, US Patent Office, 1989
9. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM: Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 1980; 19:4883-4891
10. Foster PR: Prions and blood products. Ann Med 2000; 32:501-513
11. Reichl HE, Foster PR, Welch AG, Li Q, MacGregor IR, Somerville RA, Fernie K, Steele PJ, Taylor DM: Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Vox Sang 2002; 83:137-145
12. Cai K, Miller JLC, Stenland CJ, Gilligan KJ, Hartwell RC, Terry JC, Evans-Storms RB, Rubenstein R, Petteway SR, Jr, Lee DC: Solvent-dependent precipitation of prion protein. Biochim Biophys Acta 2002; 1597:28-35
13. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohn FE, Prusiner SB: Eight prion strains have PrP (Sc) molecules with different conformations. Nat Med 1998; 10:1157-1165
14. Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J: Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171-180
15. Shaked GM, Shaked Y, Kariv-Inbal Z, Halimi M, Avraham I, Gabizon RJ: A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. Biol Chem 2001; 34:31479-31482